Use of cxcl14
AssigneeNewish Technology (Beijing) Co., Ltd.
InventorsHailong QI, Xudong WANG, Jiandong JIANG, Lulu WANG, Defang LIU, Yanling YAO, Xiaofang WANG, Zhongjie SUN
Life of this patent
Estimating the term…
Loading patent…
AssigneeNewish Technology (Beijing) Co., Ltd.
InventorsHailong QI, Xudong WANG, Jiandong JIANG, Lulu WANG, Defang LIU, Yanling YAO, Xiaofang WANG, Zhongjie SUN
Estimating the term…
The disclosure relates to the field of molecular biology, and in particular relates to the use of CXCL 14. According to the present invention, different antigen proteins are transferred to the surface of a DC cell by means of the chemotactic binding capacity of CXCL 14 and surface receptors of immune cells such as DC cells. A chemokine of CXCL14 can effectively induce the binding of an antigen molecule to a specific immune cell at the N-terminal of an antigen protein, such that the cross presentation effect of the antigen molecule is greatly enhanced, and CXCL14 can finally induce a stronger specific immune response of the antigen molecule.
A method for improving antigen presentation effect, comprising administering to a subject in need thereof at least one of I)-VI), wherein
A fusion protein, comprising CXCL14 and an antigen or comprising CXCL14, an antigen and a T2 fragment.
(canceled)
Dependencies are inferred from the claim text.